StockNews.AISignal intelligence

Signal detail

News insight

Source-backed analysis, the reasoning behind the signal, and its market context.

SCSCBullishM&AShort Term
High materiality7/10

ScanSource to Acquire MicroAge, a Leading IT Solutions Integrator

StockNews.AIAug 20, 8:25 AM EDT1 source
Trading thesisImportance 7/10

Bullish over 12–18 months as margins accrete and growth-tech exposure expands.

AI summary

What happened and why it matters

ScanSource has agreed to acquire MicroAge in an all-cash deal valued at $220.5 million, with closing anticipated in the quarter ending September 30, 2026, subject to regulatory approvals. The deal broadens ScanSource's services-led model with MSP capabilities and adds relationships with vendors like Microsoft and CrowdStrike, expanding the company's addressable market in cloud, cybersecurity, data center, and AI.

  • All-cash purchase; financed via existing credit facility, which may affect near-term leverage.
  • Adds high-margin services and growth-tech capabilities; potential revenue upside.
  • Closing timeline in Sept 2026; regulatory approvals could introduce delay risk.

Sentiment rationale

The deal is expected to be accretive to margins and non-GAAP EPS in year one and free cash flow positive, which could drive multiple expansion and investor enthusiasm; near-term leverage may rise due to cash/debt financing.

Key facts

  1. 01

    ScanSource to acquire MicroAge for $220.5 million cash.

  2. 02

    Close expected in quarter ending Sept 30, 2026.

  3. 03

    Adds higher-margin capabilities; expands reach into growth tech such as cloud, cyber, AI.

  4. 04

    MicroAge serves ~2,400 U.S. clients; partners with Microsoft, Dell, Sophos, HPE, CrowdStrike, VMware.

  5. 05

    Acquisition is accretive to gross margin, EBITDA margin, and non-GAAP EPS in year one; FCF positive.

M&A

Category: M&A. This is a strategic acquisition expanding ScanSource’s services-led growth into high-margin IT solutions and cloud/cyber offerings, supporting margin expansion and FCF improvements over 12–24 months.